Process: submission:03/10/2022 acceptance:07/30/2022 evaluation of mirna 223/125a and cobll1 expressions and ror-1 levels as reliable markers in b- chronic lymphocytic

HIGHLIGHTS

  • who: Asian Pac J Cancer and colleagues from the This study was conducted in the Oncology, Clinical Pathology, and Medical Biochemistry and Molecular Biology Departments, Faculty of Medicine, Zagazig University, Zagazig, Egypt during the period from January , to December This study included , newly diagnosed, CLL patients (, males and , females) who were diagnosed have published the article: Process: Submission:03/10/2022 Acceptance:07/30/2022 Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic, in the Journal: (JOURNAL)
  • how: The study evaluated the relationship between . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?